![Thomas Kotarakos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Kotarakos
Financieel Directeur/CFO bij
PARABILIS MEDICINES, INC.
Vermogen: - $ op 31-05-2026
Profiel
Thomas Kotarakos is Chief Financial Officer at Parabilis Medicines, Inc. starting in 2026.
Formerly, Mr. Kotarakos was Controller at Seres Therapeutics, Inc. from 2014 to 2018 and Senior VP-Finance & Business Operations at Codiak BioSciences, Inc. from 2018 to 2021.
Education includes undergraduate and graduate degrees from Bentley University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Thomas Kotarakos
| Bedrijven | Functie | Begin |
|---|---|---|
| PARABILIS MEDICINES, INC. | Financieel Directeur/CFO | 10-12-2021 |
Eerdere bekende functies van Thomas Kotarakos
| Bedrijven | Functie | Einde |
|---|---|---|
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01-12-2021 |
| SERES THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-10-2018 |
Opleiding van Thomas Kotarakos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Kies MarketScreener 
